SUPERB™

搜索文档
Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Standalone EMS Device For Comprehensive Multi-Body Area Muscle Strengthening and Firming
Globenewswire· 2025-09-04 20:30
The Pure Impact VIP™ standalone device represents a major extension of the Pure Impact™ product line and introduces an all-in-one independent unitStandalone device is launched with an enhanced Pure Impact™ feature set which provides comprehensive muscle strengthening programs that focus on multiple body areas including the: abdomen, arms, thighs, and buttocks and enables simultaneous treatment of 6 muscle groupsIn the recent McKinsey Life Sciences Practices report, 63% of GLP-1 patients seeking aesthetic se ...
Sofwave to Participate in 10th Annual Needham Virtual MedTech & Diagnostics Conference
Globenewswire· 2025-08-06 20:00
公司动态 - 公司首席执行官Louis Scafuri与首席财务官Assaf Korner将于2025年8月11日至12日参加第十届Needham虚拟医疗科技与诊断一对一会议 [1] 技术优势 - 公司采用创新同步超声平行束技术SUPERB™ 已获得FDA批准 用于改善面部线条与皱纹、提眉及紧致下巴松弛组织 同时改善上臂皮肤松弛外观 并短期改善橘皮组织外观与痤疮疤痕治疗 [2] - 公司Pure Impact™模块采用第四代EMS技术 获准用于肌肉塑形 [2] 产品定位 - 公司为全球医生提供智能、简易、有效且安全的无创美学医疗器械解决方案 [2]
Sofwave Medical Reports Record Second Quarter and First Half 2025 Financial Results and Business Highlights
Globenewswire· 2025-08-05 20:30
SAN CLEMENTE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the second quarter and first half of fiscal year 2025, for the period ended June 30, 2025, and recent business highlights. | IFRS Results | | | | --- | --- | --- | | (U.S. dollars in thousands) | | | | Q2 2025 | | Q2 2024 | | Revenue | $20,990 | $14,642 | | Gross Profit | $15,854 | $11, ...
Sofwave to Participate in Jefferies Global Healthcare Conference
Globenewswire· 2025-05-22 20:00
文章核心观点 - 索福波医疗公司首席财务官将在杰富瑞全球医疗保健会议上进行公司概况介绍并参与一对一投资者会议 [1] 会议信息 - 会议名称为杰富瑞全球医疗保健会议 [2] - 会议时间为2025年6月3 - 5日 [1] - 公司介绍时间为2025年6月5日周四上午11:05(美国东部时间) [2] - 公司介绍形式为公司概况介绍 [2] - 可点击链接观看网络直播 [2] 公司情况 - 索福波医疗是全球能量型非侵入性美容医疗设备领域的新兴领导者 [1] - 公司采用创新方法,利用专有突破性技术进行除皱、提拉和治疗橘皮组织 [2] - 其SUPERB™技术获FDA批准,可改善面部线条和皱纹、提拉眉毛、改善下巴松弛组织、改善上臂皮肤松弛、短期改善橘皮组织外观和治疗痤疮疤痕 [2] - 公司的Pure Impact™模块采用第四代EMS技术,获批用于肌肉塑形 [2] - 公司产品为医生提供智能、简单、有效且安全的美容解决方案 [2] - 公司联系邮箱为Info@sofwave.com [2] 投资者联系方式 - 投资者联系人是Brian Ritchie [2] - 所属机构为LifeSci Advisors LLC [2] - 联系电话为(212) 915 - 2578 [2] - 邮箱为britchie@lifesciadvisors.com [2]
Sofwave’s liftHD Body Contouring Applicator to Debut at the 44th Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) 2025
Globenewswire· 2025-04-24 20:30
Four abstract poster presentations highlighting clinical applications and results of Sofwave's SUPERB™ non- invasive medical aesthetic technology will also be on exhibit Launch of the liftHD body applicator provides opportunity for next generation non-invasive aesthetic body treatments which improve cellulite and skin laxity appearance in order to achieve SUPERB results beyond the face Precise depth control – The thermal treatment zone is precisely placed between 0.5mm and 1.8 mm to stimulate natural healin ...